UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 521

Sortiert nach

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (3), p.243-257

2015

Link zum Volltext

Verfügbarkeit prüfen

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1591-1599

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e37-e46

2013

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

Journal of viral hepatitis, 2007-03, Vol.14 (3), p.147-152

2007

Link zum Volltext

Verfügbarkeit prüfen

Great and rapid HBsAg decline in patients with on‐treatment hepatitis flare in early phase of potent antiviral therapy

Journal of viral hepatitis, 2018-04, Vol.25 (4), p.421-428

2018

Link zum Volltext

Verfügbarkeit prüfen

Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance – author's reply

Alimentary pharmacology & therapeutics, 2016-03, Vol.43 (5), p.655-656

Liaw, Y.‐F.

2016

Link zum Volltext

Verfügbarkeit prüfen

Letter: lessons from the ‘real‐world’ entecavir therapy in chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (7), p.846-847

2016

Link zum Volltext

Verfügbarkeit prüfen

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.138-146

2012

Link zum Volltext

Verfügbarkeit prüfen

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

International Journal of Obesity, 2007-05, Vol.31 (5), p.871-875

2007

Link zum Volltext

Verfügbarkeit prüfen

Therapy of chronic hepatitis B: current challenges and opportunities

Journal of viral hepatitis, 2002-11, Vol.9 (6), p.393-399

Liaw, Y.-F.

2002

Link zum Volltext

Verfügbarkeit prüfen

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

British journal of cancer, 2012-12, Vol.107 (12), p.2010-2015

2012

Link zum Volltext

Verfügbarkeit prüfen

Rumpel-Leede phenomenon in a diabetes mellitus patient

QJM : An International Journal of Medicine, 2015-08, Vol.108 (8), p.671-672

2015

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide hypomethylation in hepatocellular carcinogenesis

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4238-4243

2001

Link zum Volltext

Verfügbarkeit prüfen

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Alimentary Pharmacology and Therapeutics, 2007-05, Vol.25 (9), p.1029-1037

2007

Link zum Volltext

Verfügbarkeit prüfen

Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus

Journal of Clinical Microbiology, 1999-12, Vol.37 (12), p.3828-3834

1999

Link zum Volltext

Verfügbarkeit prüfen

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Hepatology (Baltimore, Md.), 1999-08, Vol.30 (2), p.567-572

1999

Link zum Volltext

Verfügbarkeit prüfen

Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case–Control Study Among Men

JNCI : Journal of the National Cancer Institute, 2001-11, Vol.93 (21), p.1644-1651

2001

Link zum Volltext

Verfügbarkeit prüfen

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

JNCI : Journal of the National Cancer Institute, 2008-08, Vol.100 (16), p.1134-1143

2008

Link zum Volltext

Verfügbarkeit prüfen

Botryomycosis presenting as nasal cutaneous fistulas caused by Prevotella melaninogenica

Clinical and experimental dermatology, 2012-07, Vol.37 (5), p.501-504

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

American journal of epidemiology, 1997-06, Vol.145 (11), p.1039-1047

1997

Link zum Volltext

Verfügbarkeit prüfen

Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.971-975

1999

Link zum Volltext

Verfügbarkeit prüfen

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis

Journal of viral hepatitis, 2006-04, Vol.13 (4), p.250-255

2006

Link zum Volltext

Verfügbarkeit prüfen

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

American journal of epidemiology, 1999-08, Vol.150 (4), p.367-374

1999

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes after interruption of entecavir therapy in HBeAg‐negative chronic hepatitis B patients with compensated cirrhosis

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (10), p.1182-1191

2015

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

Gut, 2014-10, Vol.63 (10), p.1648-1657

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 521

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(437)
Mit Volltextzugriff
(384)

Publikationsform

Artikel
(511)
Tagungsberichte
(10)

Sprache

Englisch
(469)
Japanisch
(60)
Chinesisch
(50)

Erscheinungsjahr

n.n

Thema

Humans
(394)
Science & Technology
(344)
Life Sciences & Biomedicine
(313)
Male
(257)
Biological And Medical Sciences
(251)
Medical Sciences
(235)
Adult
(227)
Female
(221)
Middle Aged
(199)
Gastroenterology & Hepatology
(171)
Infectious Diseases
(145)
Viral Diseases
(118)
Aged
(115)
Human Viral Diseases
(115)
Viral Hepatitis
(110)
Hepatitis B Virus
(87)
Gastroenterology. Liver. Pancreas. Abdomen
(84)
Adolescent
(69)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(69)
Chronic Disease
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

Great and rapid HBsAg decline in patients with on‐treatment hepatitis flare in early phase of potent antiviral therapy

Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance – author's reply

Letter: lessons from the ‘real‐world’ entecavir therapy in chronic hepatitis B patients

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

Therapy of chronic hepatitis B: current challenges and opportunities

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

Rumpel-Leede phenomenon in a diabetes mellitus patient

Genome-wide hypomethylation in hepatocellular carcinogenesis

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case–Control Study Among Men

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

Botryomycosis presenting as nasal cutaneous fistulas caused by Prevotella melaninogenica

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

Clinical outcomes after interruption of entecavir therapy in HBeAg‐negative chronic hepatitis B patients with compensated cirrhosis

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

Suchergebnisse filtern